Loading company…
Tokyo-based developer of saliva-based rapid tests for viruses including COVID-19 and influenza, often giving results within minutes.
Founded in 2016 and based in Tokyo, Japan, Nanotis Corporation makes the NANOTIS Method, a saliva-based test that can be run without specialized expertise, often within three minutes. It sells to healthcare providers, laboratories and consumers in Japan, the United States and other Asian markets, mainly through bulk orders and testing kit subscriptions. CEO and founder Lisa Sakashita leads the company, which raised JPY 250 million in a Series A round from Nipro Corporation on July 15, 2022.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in